• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Did Cameco’s (TSX:CCO) Weak Quarter Quietly Reshape Its Long-Term Uranium Story?

    Simply Wall St·08/08/2026 07:29:15
    Listen to the news
    • Cameco Corporation recently reported past second-quarter 2026 results showing net income of C$25.22 million, down from C$320.89 million a year earlier, alongside lower earnings per share for both the quarter and first half of the year, while issuing full-year 2026 revenue guidance of US$3.32 billion to US$3.57 billion and confirming a board resignation.
    • The combination of sharply reduced quarterly profitability, a defined revenue range for 2026, and the departure of a director involved in key oversight committees gives investors fresh information on both Cameco’s earnings profile and its governance at a time when expectations for long-term nuclear growth remain central to its story.
    • We’ll now examine how Cameco’s sharply weaker quarterly earnings and new 2026 revenue guidance may influence its long-term uranium investment narrative.

    AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

    Cameco Investment Narrative Recap

    Cameco’s appeal rests on belief in a durable role for nuclear power and the company’s ability to convert that into profitable uranium and fuel services. The sharp drop in second quarter earnings highlights how sensitive results can be to short term pricing and operational factors, but the new 2026 revenue guidance range keeps the near term demand story intact. For now, the most immediate risk still looks like execution and cost pressure at key mines rather than a shift in nuclear demand.

    The most relevant new data point is Cameco’s 2026 revenue guidance of US$3.32 billion to US$3.57 billion, which offers a clearer view of how management currently sees contracted volumes and pricing flowing through the income statement. Against weaker quarterly profits, this range helps frame whether recent earnings softness reflects timing and mix, or something more sustained, and therefore how well positioned Cameco might be to benefit if long term uranium contracting strengthens.

    Yet beneath this long term nuclear story, investors should be aware that operational issues at Tier 1 assets could still...

    Read the full narrative on Cameco (it's free!)

    Cameco's narrative projects CA$4.6 billion revenue and CA$1.7 billion earnings by 2029. This requires 9.4% yearly revenue growth and an earnings increase of about CA$1.0 billion from CA$650.6 million today.

    Uncover how Cameco's forecasts yield a CA$178.28 fair value, a 31% upside to its current price.

    Exploring Other Perspectives

    TSX:CCO 1-Year Stock Price Chart
    TSX:CCO 1-Year Stock Price Chart

    Lowest estimate analysts were already cautious, assuming revenue of about CA$4.0 billion and earnings of CA$1.3 billion by 2029, and after such a weak quarter they may treat Westinghouse’s AP1000 exposure and Cameco’s cost pressures as reinforcing reasons to expect a tougher path than the consensus, reminding you that informed views on the same stock can differ sharply and are likely to evolve as new results arrive.

    Explore 5 other fair value estimates on Cameco - why the stock might be worth as much as 31% more than the current price!

    Reach Your Own Conclusion

    Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

    • A great starting point for your Cameco research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
    • Our free Cameco research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cameco's overall financial health at a glance.

    No Opportunity In Cameco?

    Every day counts. These free picks are already gaining attention. See them before the crowd does:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.